A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study.

Haiyi DengJiating DengXinqing LinWenhui GuanZiying LinYanli QiuYilin YangJianhui WuGuihuan QiuNi SunMaolin ZhouJiaxi DengXiaohong XieZhanhong XieMing LiuYinyin QinYanbin ZhouCheng-Zhi Zhou

Published in: Clinical drug investigation (2023)

The simple risk-scoring model may predict severe CIP in lung cancer patients receiving ICIs. For patients with high scores, clinicians should use ICIs with caution or strengthen the monitoring of these patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
early onset
dna damage
palliative care
cell cycle
drug induced
interstitial lung disease